Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3726815019 | Antiasthmatic therapeutic role | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3726816018 | Antiasthmatic therapeutic role (role) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Antiasthmatic therapeutic role | Is a | Therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Antiasthmatic agent | Plays role | True | Antiasthmatic therapeutic role | Inferred relationship | Some | |
| Reslizumab only product in parenteral dose form | Plays role | True | Antiasthmatic therapeutic role | Inferred relationship | Some | |
| Reslizumab-containing product in parenteral dose form | Plays role | True | Antiasthmatic therapeutic role | Inferred relationship | Some | |
| Mepolizumab only product in parenteral dose form | Plays role | True | Antiasthmatic therapeutic role | Inferred relationship | Some | |
| Mepolizumab-containing product in parenteral dose form | Plays role | True | Antiasthmatic therapeutic role | Inferred relationship | Some | |
| Mepolizumab 100 mg/mL solution for injection | Plays role | True | Antiasthmatic therapeutic role | Inferred relationship | Some |
Reference Sets
Qualifier value foundation reference set
Description inactivation indicator reference set
FHIR